Cover image
Volume 8, Issue 3, July 2019
ORIGINAL ARTICLES
Incidence of Healthcare-Associated Influenza-Like Illness After a Primary Care Encounter Among Young Children
A Multicenter Consortium to Define the Epidemiology and Outcomes of Pediatric Solid Organ Transplant Recipients With Inpatient Respiratory Virus Infection
The Burden of Congenital Cytomegalovirus Infection: A Prospective Cohort Study of 20 000 Infants in Finland
In our population-based screening study, the burden of congenital cytomegalovirus (cCMV) infection was low; the prevalence was only 0.2%, and neurodevelopmental, ophthalmological, and hearing outcomes in the CMV-positive infants did not differ from those of matched healthy controls at 18 months of age.
BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial
In this large-scale randomized controlled trial that included 4262 Danish infants, vaccination against BCG did not affect the rate of hospitalization for infection up to the age of 15 months. In future studies, the role of maternal vaccination against BCG, premature birth, and cesarean delivery in BCG-vaccinated children needs further exploration.
Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin–Tazobactam or Cefepime: A Cohort Study
In this matched-cohort study of pediatric inpatients, 28.9% of those treated with a combination of piperacillin–tazobactam and vancomycin developed acute kidney injury, compared to 7.9% in those treated with cefepime and vancomycin (P < .001).
Clinical Features and Outcomes of Children with Culture-Negative Septic Arthritis
Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection
Capsule-Negative emm Types Are an Increasing Cause of Pediatric Group A Streptococcal Infections at a Large Pediatric Hospital in Texas
Disease caused by group A Streptococcus (GAS) remains a substantial burden in pediatric populations. We are witnessing a shift in the epidemiology of GAS disease with increasing frequency of capsule-negative serotypes in the Houston, Texas, metropolitan area.
INVITED REVIEW
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms
Several β-lactam agents with activity against carbapenem-resistant organisms have been approved by the US Food and Drug Administration, and more are in the pipeline. The goal of this review is to assist infectious disease practitioners with understanding when to preferentially select 1 agent over another when treating patients infected with a carbapenem-resistant organism.
BRIEF REPORTS
Clinical Characterization of Invasive Disease Caused by Haemophilus influenzae Serotype b in a High Vaccination Coverage Setting
Clinical Manifestations and Bacterial Genomic Analysis of Group A Streptococcus Strains That Cause Pediatric Toxic Shock Syndrome
Clinical and Genomic Features of the First Cases of Elizabethkingia anophelis Infection in New York, Including the First Case in a Healthy Infant Without Previous Nosocomial Exposure
Oral Management for Pediatric Lyme Meningitis
We identified 38 patients diagnosed with Lyme meningitis. Thirty-two of these patients had exclusively oral therapy with doxycycline and amoxicillin after their discharge, and 2 of them developed potential adverse effects from oral doxycycline therapy. All patients treated with oral antibiotics had experienced resolution of their symptoms at their follow-up visit.
